• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Biotechnology’s Role in Improving Stroke Outcomes

    CEO Spotlight: Marc Kikuchi

    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AskBio Appoints Clinical Ops Executives

    SpectrumX Partners With UK Contract Manufacturer

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    SpectrumX Partners With UK Contract Manufacturer

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Catalent to Acquire Metrics Contract Services for $475M
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    UPS to Acquire Healthcare Logistics Provider Bomi Group

    Marken to Acquire Medical Courier Business of Cedra Express

    5 Key Features of Agile Pharmaceutical Packaging Supply Chains That Drive Results

    Novavax Expands Manufacturing Agreement with SK bioscience

    Lonza Continues to Lead the Market with Innovative Hard Empty Capsules
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    West Pharmaceutical Makes Strategic Investment in Latch Medical

    “3 Key Trends” with James Park

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Behind Every Successful eCOA Solution is a Robust Scientific Strategy
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Chime Biologics Receives Commercial Manufacturing License

    Automation Is Key to Meeting Demands in Pharmacovigilance

    UBC Acquires Examoto

    Responding to Consumer Complaints While Working with CMOs

    WuXi Vaccines Receives GMP Certificate from HPRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    IDT Biologika

    Quotient Sciences

    Baxter BioPharma Solutions

    Societal CDMO

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    IDT Biologika

    Quotient Sciences

    Baxter BioPharma Solutions

    Societal CDMO

    Aphena Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Charles River Provides Access to Cosmic Antibody Library

    Expanded antibody library launched by Distributed Bio aims to expedite the drug discovery process

    Related CONTENT
    • Charles River Acquires Retrogenix
    • Charles River Labs Acquires Distributed Bio
    • Charles River, Bit Bio Enter Strategic Pact
    • Inceptua, Bendalis Enter Oncology Clinical Supply Pact
    • Navigating a Competitive CRO Landscape
    12.12.19
    Charles River Laboratories International, Inc. will provide clients exclusive access to the new Cosmic antibody library launched by Distributed Bio, Inc., a global provider of computational optimization of fully human monoclonal antibody libraries.
     
    Distributed Bio’s new Cosmic antibody library encompasses over one-hundred billion fully human antibodies, computationally optimized for therapeutic developability and complementarity-determining regions (CDRs) sourced and incorporated at specific frequencies for maximum library diversity.
     
    Cosmic antibodies are entirely human by design with therapeutically favorable, unmutated frameworks. This phage-display antibody library was designed with immunogenicity in mind, the result is a library of leads with highly attractive profiles including nano- to picomolar potency, high expression levels, thermostability, non-immunogenicity, and soluble, aggregation-resistant features.
     
    In 2018, Distributed Bio entered an exclusive partnership with Charles River providing access to its antibody libraries and integrated antibody optimization technologies. A combination of Distributed Bio’s antibody libraries and Charles River’s drug development expertise creates a unique platform for therapeutic antibody discovery and development. The partnership aims to continue to increase the probability of success for delivering high-quality antibody candidates.
     
    “The new Cosmic antibody library will provide our clients with access to a truly differentiated library, with delivery of exclusive antibody leads in just three months—substantially reducing the risk of first to file,” said Birgit Girshick, corporate executive vice president, Discovery & Safety Assessment, Biologics Testing Solutions, and Avian Vaccine Services at Charles River.
     
    “By providing Charles River’s clients exclusive access to the Cosmic antibody library, we are excited to help increase success in early drug discovery by delivering qualified leads. Leveraging our revolutionary antibody discovery and engineering platforms and Charles River’s downstream capabilities, our partnership delivers a comprehensive research experience from idea to clinic,” said Jacob Glanville, Ph.D., founding partner, chief executive officer, and president at Distributed Bio.
    Related Searches
    • executive vice president
    • discovery
    • biologics
    • www.contractpharma.com
    Suggested For You
    Charles River Acquires Retrogenix Charles River Acquires Retrogenix
    Charles River Labs Acquires Distributed Bio Charles River Labs Acquires Distributed Bio
    Charles River, Bit Bio Enter Strategic Pact Charles River, Bit Bio Enter Strategic Pact
    Inceptua, Bendalis Enter Oncology Clinical Supply Pact     Inceptua, Bendalis Enter Oncology Clinical Supply Pact
    Navigating a Competitive CRO Landscape Navigating a Competitive CRO Landscape
    Stevanato, Duoject Enter Auto-injector Collaboration Stevanato, Duoject Enter Auto-injector Collaboration
    AAPS Exhibitor List AAPS Exhibitor List
    BioIVT Acquires PPA Research Group BioIVT Acquires PPA Research Group
    AIT Bioscience Names New CEO AIT Bioscience Names New CEO
    Veeva Systems Acquires Crossix Solutions Veeva Systems Acquires Crossix Solutions
    Guidelines in Toxicology: A Blessing and a Curse Guidelines in Toxicology: A Blessing and a Curse
    Enable Injections, Genentech Form Partnership Enable Injections, Genentech Form Partnership
    Alvotech, Cipla Gulf Ink Biosimilar Deal Alvotech, Cipla Gulf Ink Biosimilar Deal
    AbbVie AbbVie
    Gilead Inks 10-year $5B Deal with Galapagos Gilead Inks 10-year $5B Deal with Galapagos

    Related Breaking News

    • Bioanalytical Services | Breaking News | CRO News | Industry News
      Charles River Acquires Retrogenix

      Charles River Acquires Retrogenix

      Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.
      Tim Wright, Editor, Contract Pharma 04.05.21

    • Breaking News | CRO News | Drug Discovery | Preclinical Outsourcing
      Charles River Labs Acquires Distributed Bio

      Charles River Labs Acquires Distributed Bio

      Establishes integrated, large molecule discovery platform.
      Contract Pharma Staff 01.04.21

    • Biologics, Proteins, Vaccines | Breaking News | CRO News | Drug Discovery
      Charles River, Bit Bio Enter Strategic Pact

      Charles River, Bit Bio Enter Strategic Pact

      Partnership will leverage Bit Bio’s unique ability to generate authentic human cells at scale
      12.10.19


    • Breaking News | Clinical Trial Materials | Industry News
      Inceptua, Bendalis Enter Oncology Clinical Supply Pact

      Inceptua, Bendalis Enter Oncology Clinical Supply Pact

      Inceptua gains exclusive access to Bendalis’ portfolio of chemotherapy products commonly used in clinical trials
      11.25.19

    • Clinical Trials | CRO News | Laboratory Testing | Toxicology
      Navigating a Competitive CRO Landscape

      Navigating a Competitive CRO Landscape

      Jacob McDonald of Lovelace Biomedical looks at consolidation in an increasingly competitive environment
      Jake McDonald, Ph.D., Chief Scientific Officer, Lovelace Biomedical 11.15.19

    Loading, Please Wait..
    Trending
    • Almac Invests $65M To Expand North American HQ
    • Just – Evotec Biologics And Alpine Immune Sciences Expand Partnership
    • West Pharmaceutical Makes Strategic Investment In Latch Medical
    • AskBio Appoints Clinical Ops Executives
    • Catalent To Acquire Metrics Contract Services For $475M
    Breaking News
    • AskBio Appoints Clinical Ops Executives
    • GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    • SpectrumX Partners With UK Contract Manufacturer
    • Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership
    • Almac Invests $65M to Expand North American HQ
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Biotechnology’s Role in Improving Stroke Outcomes
    • CEO Spotlight: Marc Kikuchi
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Aug. 13
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Consumers are Clamoring for Vintage Glam: Spate
    Kayali’s Lovefest Fragrance, Newell’s New Candle and HydraFacial’s Record Financial Results
    Self Care Trumps Home Care Post-Covid
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Aug. 13
    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login